Unknown

Dataset Information

0

HMGB1 mediates microbiome-immune axis dysregulation underlying reduced neutralization capacity in obesity-related post-acute sequelae of SARS-CoV-2.


ABSTRACT: While obesity is a risk factor for post-acute sequelae of SARS-CoV-2 infection (PASC, "long-COVID"), the mechanism(s) underlying this phenomenon remains poorly understood. To address this gap in knowledge, we performed a 6-week longitudinal study to examine immune activity and gut microbiome dysbiosis in post-acute stage patients recovering from SARS-CoV-2 infection. Self-reported symptom frequencies and blood samples were collected weekly, with plasma assessed by ELISA and Luminex for multiple biomarkers and immune cell profiling. DNA from stool samples were collected at the early stage of recovery for baseline assessments of gut microbial composition and diversity using 16S-based metagenomic sequencing. Multiple regression analyses revealed obesity-related PASC linked to a sustained proinflammatory immune profile and reduced adaptive immunity, corresponding with reduced gut microbial diversity. In particular, enhanced signaling of the high mobility group box 1 (HMGB1) protein was found to associate with this dysregulation, with its upregulated levels in plasma associated with significantly impaired viral neutralization that was exacerbated with obesity. These findings implicate HMGB1 as a candidate biomarker of PASC, with potential applications for risk assessment and targeted therapies.

SUBMITTER: Rubas NC 

PROVIDER: S-EPMC10764757 | biostudies-literature | 2024 Jan

REPOSITORIES: biostudies-literature

altmetric image

Publications

HMGB1 mediates microbiome-immune axis dysregulation underlying reduced neutralization capacity in obesity-related post-acute sequelae of SARS-CoV-2.

Rubas Noelle C NC   Peres Rafael R   Kunihiro Braden P BP   Allan Nina P NP   Phankitnirundorn Krit K   Wells Riley K RK   McCracken Trevor T   Lee Rosa H RH   Umeda Lesley L   Conching Andie A   Juarez Ruben R   Maunakea Alika K AK  

Scientific reports 20240103 1


While obesity is a risk factor for post-acute sequelae of SARS-CoV-2 infection (PASC, "long-COVID"), the mechanism(s) underlying this phenomenon remains poorly understood. To address this gap in knowledge, we performed a 6-week longitudinal study to examine immune activity and gut microbiome dysbiosis in post-acute stage patients recovering from SARS-CoV-2 infection. Self-reported symptom frequencies and blood samples were collected weekly, with plasma assessed by ELISA and Luminex for multiple  ...[more]

Similar Datasets

| S-EPMC5450936 | biostudies-literature
| S-EPMC6953162 | biostudies-literature
| S-EPMC4922538 | biostudies-literature
| S-EPMC8379951 | biostudies-literature
| S-EPMC5075578 | biostudies-literature
| S-EPMC6123379 | biostudies-literature
| S-EPMC8902634 | biostudies-literature
2021-09-17 | GSE176201 | GEO
| S-EPMC9854035 | biostudies-literature
| S-EPMC3672339 | biostudies-literature